Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific... – Lipid or oil
Patent
1995-06-07
1998-10-13
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
Lipid or oil
424450, 4241841, 424812, 424 121, 436529, 436535, 514885, A61K 9127, A61K 4500, A61K 3900, A61K 39395
Patent
active
058208739
ABSTRACT:
The present invention provides a novel class of polyethylene glycol modified ceramide lipids. The lipids can be used to form liposomes optionally containing various biological agents or drugs, such as anti-cancer agents. In addition, methods of use for the liposomes are provided.
REFERENCES:
patent: 4089801 (1978-05-01), Schneider
patent: 4460560 (1984-07-01), Tokes et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4534899 (1985-08-01), Sears
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4617186 (1986-10-01), Schafer et al.
patent: 4650909 (1987-03-01), Yoakum
patent: 4728575 (1988-03-01), Gamble et al.
patent: 4737323 (1988-04-01), Martin et al.
patent: 4752425 (1988-06-01), Martin et al.
patent: 4837028 (1989-06-01), Allen
patent: 4861521 (1989-08-01), Suzuki et al.
patent: 4920016 (1990-04-01), Allen et al.
patent: 4925661 (1990-05-01), Huang
patent: 4943624 (1990-07-01), Regen
patent: 4944948 (1990-07-01), Uster et al.
patent: 4963367 (1990-10-01), Ecanow
patent: 5008109 (1991-04-01), Tin
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5064655 (1991-11-01), Uster et al.
patent: 5153000 (1992-10-01), Chikawa et al.
patent: 5185154 (1993-02-01), Lasic et al.
patent: 5206027 (1993-04-01), Kitaguchi
patent: 5213804 (1993-05-01), Martin et al.
patent: 5225212 (1993-07-01), Martin et al.
patent: 5288499 (1994-02-01), Janoff et al.
patent: 5356633 (1994-10-01), Woodle et al.
patent: 5395619 (1995-03-01), Zalipsky et al.
patent: 5527528 (1996-06-01), Allen et al.
patent: 5543152 (1996-08-01), Webb et al.
patent: 5552155 (1996-09-01), Bailey et al.
patent: 5593622 (1997-01-01), Yoshioka et al.
Blume, et al., "Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times," 1993, Biochimica et Biophysica Acta., 1149:180-184.
Chonn, et al., "Ganglioside G.sub.M1 and hydrophilic polymers increase liposome circulation times by inhibiting the association of blood proteins," 1992, J. Liposome Res., 2(3):397-410.
Danishefsky, et al., "Total Synthesis of Zincophorin," 1988, J. Am. Chem. Soc., 1988, 110:4368-4378.
Gregoriadis, et al., "Coupling of ligands to liposomes independently of solute entrapment; observations on the formed vesicles," 1993, Biochimica et Biophysica Acta., 1147:185-193.
Huang, et al., "Extravasation and Transcytosis of Liposomes in Kaposi's Sarcoma-Like Dermal Lesions of Transgenic Mice Bearing the HIV Tat Gene," 1993, American Journal of Pathology, 143(1):10-14.
Kiso, et al., "A Convenient Synthesis of Sphingosine and Ceramide from D-Xylose or D-Galactose," 1986, J. Carbohydrate Chemistry, 5(2):335-340.
Klibanov, et al., "Activity of amphipathic poly(ethyleneglycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target," 1991, Biochimica et Biophysica Acta., 1062:142-148.
Liu, et al., "Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM.sub.1 -containing liposomes," 1992, Biochimica et Biophysica Acta., 1104:95-101.
Mori, et al., "Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM.sub.1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo," 1991, FEBS Letters, 284(2):263-266.
Nicolaou, et al., "A Practical and Enantioselective Synthesis of Glycosphingolipids and Related Compounds. Total Synthesis of Globotriaosylceramide (Gb.sub.3)," 1988, J. Am. Chem. Soc., 110:7910-7912.
Oikawa, et al., "Selective hydrogenolysis of the benzyl protecting group for hydroxy function with Raney nickel in the presence of the MPM (4-methoxybenzyl) and DMPM (3,4-dimethoxybenzyl) protecting groups," 1984, Tetrahedron Letters, 25(47):5397-5400.
Parr, et al., "Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles," Jun. 19-22, 1994, Liposome Research Days Conference--Liposomes: The Next Generation, University of British Columbia.
Parr, et al., "Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles," 1994, Biochimica et Biophysica Acta, 1195:21-30.
Reed, et al., "Generation of targets for alloreactive CTL using purified H-2K.sup.k in liposomes and polyethylene glycol," 1986, Molecular Immunology, 23(12):1339-1347.
Schmidt, et al., "Lactosylceramides with Unsaturated Fatty Acids--Synthesis and Use in the Generation of Bilayer Membranes," 1987, Angew. Chem. Int. Ed. Engl., 26(8):793-794.
Torchilin, et al., "Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium," 1992, The FASEB Journal, 6:2716-2719.
Wang, et al., "pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse," 1987, Proc. Natl. Acad. Sci. USA, 84:7851-7855.
Abuchowski, et al., "Treatment of L5178Y Tumor-Bearing BDF Mice With a Nonimmunogenic L-Glutaminase-L-Asparaginase,"Cancer Treatment Reports, 63(6):1127-1132 (1979).
Abuchowski, et al., "Immunosuppressive Properties and Circulating Life of Achromobacter Glutaminase-Asparaginase Covalently Attached to Polyethylene Glycol in Man," Cancer Treatment Reports, 65(11-12):1077-1081 (1981).
Berger, Jr., et al., "Preparation of Polyethylene Glycol-Tissue Plasminogen Activator Adducts That Retain Functional Activity: Characteristics and Behavior in Three Animal Species," Blood, 71(6):1641-1647 (1988).
Allen, T., Journal of Liposome Research, 2(3):289-305 (1992).
Chu, et al., Journal of Liposome Research, 4(1):361-395 (1994).
Gao, et al., Journal of Liposome Research, 3(1):17-30 (1993).
Klibanov, et al., Journal of Liposome Research, 2(3):321-334 (1992).
Soehnlein, et al., Seifen, Ole, Fette, Wachse, 115(3):85-86 (1989).
Hyde et al. Nature. vol. 362. 18 Mar. 1993.
Choi Lewis S. L.
Madden Thomas D.
Webb Murray S.
Achutamurthy Ponnathapura
Ponnaluri Padmashri
The University of British Columbia
LandOfFree
Polyethylene glycol modified ceramide lipids and liposome uses t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyethylene glycol modified ceramide lipids and liposome uses t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyethylene glycol modified ceramide lipids and liposome uses t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-310960